The most common adverse events reported with both treatments were mild to moderate gastrointestinal-related side effects. Tirzepatide provided superior weight loss when compared with semaglutide in ...

The discontinuation of STRIDES is a rare stumble for the next-generation obesity field and comes just weeks after Amgen ...

A study reveals that weight loss can lead to significant healthcare savings, with 7% savings for a 5% BMI reduction and 30% ...

Another drug Tirzepatide is sold as injection ... Obesity has been declared a ‘disease' by WHO. It is associated not only with heart disease, diabetes, stroke, gallstones, osteoarthritis ...

Eli Lilly is aggressively ramping up its manufacturing capacity for tirzepatide as compounding pharmacies continue to ...

Data continue to show that tirzepatide, called Mounjaro for type 2 diabetes and Zepbound for weight loss, is safe and effective, but side effects remain.

Weight loss jab tirzepatide – commonly sold under the brand name Mounjaro – is set to become available via the NHS for ...

Wegovy, Ozempic, Mounjaro and retatrutide – the ‘miracle’ drugs are booming. We assess whether they’re safe and how they ...

Eli Lilly's weight-loss drug Zepbound outperformed Novo Nordisk's Wegovy in a head-to-head trial, leading to a rise ...